Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.290
+0.110 (9.32%)
Nov 4, 2024, 4:00 PM EST - Market closed

Spero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
707890518527184
Upgrade
Market Cap Growth
-7.93%-13.02%-82.69%-1.83%186.63%73.81%
Upgrade
Enterprise Value
11-104640140895
Upgrade
Last Close Price
1.291.471.7316.0119.399.62
Upgrade
PE Ratio
3.963.42-1.40-5.51-5.51-2.87
Upgrade
PS Ratio
0.580.751.6728.3556.5010.13
Upgrade
PB Ratio
0.870.731.185.863.992.47
Upgrade
P/FCF Ratio
-4.88-2.36-11.59-8.04-6.13-3.65
Upgrade
P/OCF Ratio
-4.88-2.36-11.59-8.04-6.14-3.68
Upgrade
EV/Sales Ratio
0.09-0.100.8621.9843.725.24
Upgrade
EV/EBITDA Ratio
0.53-0.37-1.55-4.60-5.21-1.52
Upgrade
EV/EBIT Ratio
0.53-0.38-1.51-4.56-5.16-1.50
Upgrade
EV/FCF Ratio
0.480.31-5.95-6.24-4.74-1.89
Upgrade
Debt / Equity Ratio
0.060.050.090.630.060.07
Upgrade
Debt / EBITDA Ratio
0.220.19----
Upgrade
Debt / FCF Ratio
-0.34-0.17-0.86-0.87-0.09-0.11
Upgrade
Asset Turnover
0.950.680.360.110.070.15
Upgrade
Quick Ratio
2.613.425.097.989.283.40
Upgrade
Current Ratio
2.683.535.258.469.703.58
Upgrade
Return on Equity (ROE)
25.81%24.95%-56.53%-81.47%-75.77%-63.99%
Upgrade
Return on Assets (ROA)
10.48%10.90%-12.91%-33.88%-38.10%-33.61%
Upgrade
Return on Capital (ROIC)
17.82%17.17%-16.86%-38.73%-44.95%-40.32%
Upgrade
Earnings Yield
25.03%29.27%-51.82%-17.34%-14.85%-33.13%
Upgrade
FCF Yield
-20.63%-42.35%-8.63%-12.43%-16.32%-27.37%
Upgrade
Buyback Yield / Dilution
-12.90%-40.98%-21.65%-38.01%-23.27%-13.49%
Upgrade
Total Shareholder Return
-12.90%-40.98%-21.65%-38.01%-23.27%-13.49%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.